Improving BP Control in Diverse Populations Using BP MAP

You may be eligible if

• ACTIVE CLINICS
• For inclusion as an Active Clinic in this study, clinics may participate must be able to identify:
• A Site Champion who works at the clinic and who is willing to take primary responsibility for implementing the M.A.P. intervention
• A Physician Champion who works at the clinic and who is willing to advocate actively for the M.A.P. intervention
• A Practice Change Facilitator willing to attend a 1-day training and help guide implementation of the M.A.P intervention for Full Support sites, with the support of AMA staff (may be the Site Champion or Physician Champion, or a person with regional responsibilities who can support multiple sites)
• Sites will be excluded if they:
• Have implemented any high blood pressure quality improvement component from the M.A.P. BP improvement program as part of Target: BP or from the AMA or Target: BP websites
• Are currently involved in an ongoing clinical trial or grant funded project related to high blood pressure or hypertension
• USUAL CARE CLINICS:
• Usual Care Clinics will include PCORnet Datamarts participating in BP TRACK, a concurrently-running BP Control Registry within PCORnet that will provide quarterly datamart-level estimates of BP control and other aggregate metrics relevant to BP control. All participating datamarts will be included, with the following exceptions:
• Datamarts with any Active Clinics participating in BP MAP will be excluded
• Datamarts that obscure dates via date-shifting will be excluded, as this will not allow for control of concurrent secular trends
• PATIENTS
• Within clinics (Active or Usual Care), patients will be eligible (and identified from the electronic health record) if they meet National Quality Forum BP Control Metric (NQF 0018) criteria:
• Age 18-85 on the date of analysis
• At least one outpatient encounter with a diagnosis of hypertension during the first six months of the measurement year (ending on the date of analysis)
• No diagnosis or evidence of end-stage renal disease on or prior to the end of the measurement year
• No pregnancy during the measurement year
• No admission to an inpatient setting during the measurement year